
Join to View Full Profile
500 University DrHershey, PA 17033
Phone+1 717-531-8887
Fax+1 717-531-4475
Dr. Raman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jay D. Raman is a Professor and Chair of the Department of Urology at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania. He is a nationally recognized urologic oncologist and minimally invasive surgeon with clinical and research expertise spanning prostate cancer, upper-tract and bladder urothelial carcinoma, kidney cancer, and advanced endoscopic and robotic surgery.
Dr. Raman earned his Bachelor of Science from the Massachusetts Institute of Technology and his Doctor of Medicine from Weill Cornell Medical College. He completed residency training in general surgery and urology at New York-Presbyterian Hospital/Weill Cornell Medical Center, followed by a fellowship in Minimally Invasive Urologic Surgery at the University of Texas Southwestern Medical Center.
His academic work focuses on urothelial carcinoma, kidney cancer, prostate cancer imaging, surgical complications, biomarkers, and kidney-sparing therapies. Dr. Raman has authored more than 300 peer-reviewed publications and has served as an investigator on numerous clinical trials evaluating novel diagnostic and therapeutic strategies in urologic oncology. He is actively involved in national guideline development and urologic education, including leadership roles within the American Urological Association, the Society of Academic Urology, and the American Board of Urology.
Dr. Raman’s contributions to clinical care, education, and research have been widely recognized. He is a recipient of the AUA Mid-Career Award and has been consistently named a Castle Connolly Top Doctor. He also serves on editorial boards for leading urologic journals and is a frequent invited speaker at national and international meetings.
Clinical Expertise
- Prostate cancer, Laparoscopy, Ureteroscopy, Nephrectomy, Prostatectomy, Urologic oncology, Minimally invasive urologic surgery, Biopsies, Hydronephrosis, Kidney cancer, Bladder cancer, Testicular cancer, Medical education, Robotic surgery, Lymph node excision, Logistic models, Robotic prostatectomy, Robotic partial nephrectomy, Combined modality therapy, Adrenal disease, Health outcomes research, Neoplasm staging, Tumor imaging, Kidney Neoplasms, Local Neoplasm Recurrence, Prognosis, Retrospective Studies, Urologic Neoplasms
Education & Training
University of Texas Southwestern Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2003
Weill Cornell MedicineClass of 2001
Massachusetts Institute of TechnologyB.S., 1997
Certifications & Licensure
PA State Medical License 2008 - 2026
NY State Medical License 2003 - 2008
TX State Medical License 2007 - 2008
American Board of Urology Urology- American College of SurgeonsFellow
- Endourology SocietyFellowship Certification
- Society of Urologic OncologyMember
Awards, Honors, & Recognition
- First Place 42nd Annual Ralph E. Hopkins Urology Seminar, 2023
- Top Doctors Castle Connolly, 2020-2023
- AUA Distinguished Service Nominee Mid-Atlantic Section of AUA, 2019
Clinical Trials
- The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study Start of enrollment: 2017 Apr 04
- Multi Institutional Study in Patient Presenting With Hematuria Start of enrollment: 2017 Mar 31
- Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer Start of enrollment: 2017 Jun 20
Publications & Presentations
PubMed
- Diagnosis, evaluation, and management of patients with non-muscle invasive bladder cancer.Sri Saran Manivasagam, Amar Kassim, Jay D Raman
Future Science OA. 2026-12-01 - Diagnostic dilemmas for upper-tract urothelial carcinoma (UTUC)-grade discordance between endoscopic biopsy and final surgical pathology.Rachel Blansfield, Jay D Raman, Patrick Hensley, Surena F Matin, Garrett Ungerer
Urologic Oncology. 2026-06-01 - Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.Philipp Korn, Mark Essien, Maximilian Pallauf, Joseph Cheaib, Soum Lokeshwar
World Journal of Urology. 2026-05-22
Journal Articles
- Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
- Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell CarcinomaBrian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology
- TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinomaYoussef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V, World J Urol, 1/1/2015
Books/Book Chapters
Lectures
- Evaluation and management of urinary tract bleeding: from asymptomatic microhematuria to intractable hemorrhagic cystitis1/1/2015
- Upper-tract Urothelial Carcinoma: controversies and considerationsWashington, DC - 1/1/2015
- Surgical management of urothelial carcinoma with squamous differentiation1/1/2014
Authored Content
- Highlights from AUA 2023May 2023
- AUA Hybrid Format SuccessMay 2022
- Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Press Mentions
Biden’s Prostate Cancer Diagnosis Should Serve as Reminder to Men to Get ScreenedMay 19th, 2025
Penn State Health Offers Innovative Aquablation Therapy to Treat Enlarged ProstateJuly 15th, 2024
College of Medicine Researchers Discover Different Types of Bladder Cancer Cells Share Common Genetic AncestryMarch 29th, 2023
Grant Support
- Nanojacket delivery of novel antibioticsPenn State Clinical Translational Science Institute (CTSI)2015–2017
Committees
- Oral Certifying Examination, American Board of Urology 2022 - Present
- Chair, Office of Education, American Urological Association 2021 - Present
- Chair, AUA Video Education Committee 2016 - Present
- Chair-Elect, AUA Office of Education 2020 - 2020
- Urology Advisor Council, American College of Surgeons 2017 - 2023
Research History
- Minimally invasive surgical fellowUTSW Medical Center2007 - 2008
Professional Memberships
- Member
- Member
- Member
- Member
- Member
External Links
- Penn State Healthhttp://pennstatehershey.org/findaprovider/provider/1778
- Penn State Researchhttp://pennstate.pure.elsevier.com/en/persons/jay-raman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


























